Premera Blue Cross is requesting stakeholder feedback by March 5, 2026 on a list of policies that includes 7.01.508: “Blepharoplasty, Blepharoptosis and Brow Ptosis Surgery.” The source material provides only the policy number and title; it contains no redlined language, coverage criteria, coding, or clinical guidance for these procedures. Because the document is an administrative notice, there is no basis to infer changes to indications, documentation, or preauthorization requirements for blepharoplasty, ptosis, or brow ptosis surgery. Providers should note the inclusion of 7.01.508 in the feedback request and submit comments by the deadline if they wish to influence any forthcoming substantive revisions.
March 5, 2026 Revision: Inclusion of `7.01.508` in Feedback Request
This document is a request for feedback on multiple upcoming policies with a submission deadline of March 5, 2026. Within the list of policies provided, the specific item for ophthalmology is 7.01.508, Policy Title = Blepharoplasty, Blepharoptosis and Brow Ptosis Surgery. The only explicit procedural or topical identifier included for ophthalmology in the source is that exact policy title and its policy number; no substantive changes, criteria, or new language for 7.01.508 are presented in the text.
Therefore, the principal change noted in this revision packet is its inclusion among several policies solicited for stakeholder comment by the March 5, 2026 deadline. The source text does not provide any redlined or replacement language for 7.01.508 itself, nor does it describe modifications to coverage criteria, CPT codes, or clinical definitions for blepharoplasty, blepharoptosis, or brow ptosis surgery.
Scope Statement: What the Document Lists for `7.01.508`
The source document identifies 7.01.508 only by number and title: Blepharoplasty, Blepharoptosis and Brow Ptosis Surgery. No additional descriptive text, clinical criteria, or coverage determinations associated with that policy number are included in the provided material.
As presented, the policy entry functions as an item in a list of policies subject to review, rather than as a standalone policy excerpt. There is no information in the source text about covered indications, exclusions, preauthorization requirements, or associated CPT/HCPCS codes for 7.01.508.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.